Literature DB >> 21864743

Treatment of type 1 diabetes in children and adolescents using modern insulin pumps.

Olga Kordonouri1, Reinhard Hartmann, Thomas Danne.   

Abstract

In the last decades, we are experiencing an increasing use of insulin pumps for the treatment of type 1 diabetes in children and adolescents. The most frequent reasons for switching from insulin injection schemes to pump therapy are frequent and/or severe hypoglycaemia, dawn phenomenon, poor glycaemic control, wish for more flexibility in daily life, and needle phobia. In toddlers and preschoolers, pumps are frequently introduced from the onset of type 1 diabetes. Pumps offer the possibility of adjusting basal insulin rates individually on an age-depended manner as well as of optimizing meal-related insulin requirements according to the meal composition by using three different kinds of boluses. Structured and intensive education of patients and their families on basics and specific requirements of insulin pump therapy is essential in order to get them familiar with the devices and their features. There is increasing evidence both from multicentre cross-sectional studies as well as from meta-analyses of randomized clinical trials in paediatric populations showing that patients with pump therapy can achieve a more favourable metabolic control accompanied with less hypoglycaemic events than those with multiple daily injections.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864743     DOI: 10.1016/S0168-8227(11)70027-4

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

Review 1.  Management of type 1 diabetes in children and adolescents.

Authors:  Vandana Jain
Journal:  Indian J Pediatr       Date:  2013-10-11       Impact factor: 1.967

2.  A Comparison of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injection in Children with Type I Diabetes in Kuwait: Glycemic Control, Insulin Requirement, and BMI.

Authors:  Mohammad Mousa; Maria Al-Mahdi; Hala Al-Sanaa; Hessa Al-Kandari
Journal:  Oman Med J       Date:  2015-09

3.  A multicentre randomized controlled trial of an empowerment-inspired intervention for adolescents starting continuous subcutaneous insulin infusion--a study protocol.

Authors:  Anna Lena Brorsson; Janeth Leksell; Gunnel Viklund; Anna Lindholm Olinder
Journal:  BMC Pediatr       Date:  2013-12-20       Impact factor: 2.125

4.  Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China.

Authors:  Sicui Hu; Hongxiu Yang; Zhihong Chen; Xuefei Leng; Cheng Li; Lingyan Qiao; Weiqing Lv; Tang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-30       Impact factor: 5.555

5.  Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.

Authors:  Carolina Spinelli Alvarenga; Rebecca Ortiz La Banca; Rhyquelle Rhibna Neris; Valéria de Cássia Sparapani; Miguel Fuentealba-Torres; Denisse Cartagena-Ramos; Camila Lima Leal; Marcos Venicio Esper; Lucila Castanheira Nascimento
Journal:  BMC Endocr Disord       Date:  2022-02-19       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.